Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000950170-24-129613
Filing Date
2024-11-21
Accepted
2024-11-21 13:19:06
Documents
1
Period of Report
2024-04-01

Document Format Files

Seq Description Document Type Size
1 3/A ownership.html 3/A  
1 3/A ownership.xml 3/A 3863
  Complete submission text file 0000950170-24-129613.txt   5546
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Reporting) CIK: 0000315066 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3/A | Act: 34 | File No.: 001-39941 | Film No.: 241483343

Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Issuer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)